Shenzhen - Delayed Quote CNY

Guangdong Biolight Meditech Co., Ltd. (300246.SZ)

6.66 +0.14 (+2.15%)
As of 12:39 PM GMT+8. Market Open.
Loading Chart for 300246.SZ
DELL
  • Previous Close 6.52
  • Open 6.31
  • Bid 6.66 x --
  • Ask 6.67 x --
  • Day's Range 6.48 - 6.69
  • 52 Week Range 5.07 - 12.79
  • Volume 2,540,800
  • Avg. Volume 6,463,499
  • Market Cap (intraday) 1.762B
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 20.81
  • EPS (TTM) 0.32
  • Earnings Date --
  • Forward Dividend & Yield 0.20 (3.07%)
  • Ex-Dividend Date May 25, 2023
  • 1y Target Est --

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG monitoring equipment, fetal monitors, hemodialysis products, medical products, monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. The company was founded in 1993 and is headquartered in Zhuhai City, China.

www.blt.com.cn

1,378

Full Time Employees

December 31

Fiscal Year Ends

Related News

Q1 2024 JetBlue Airways Corp Earnings Call

Q1 2024 LKQ Corp Earnings Call

US banning TikTok? Your key questions answered

US banning TikTok? Your key questions answered

Q1 2024 General Electric Co Earnings Call

Q1 2024 Spotify Technology SA Earnings Call

Performance Overview: 300246.SZ

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300246.SZ
35.34%
SSE Composite Index
1.92%

1-Year Return

300246.SZ
36.14%
SSE Composite Index
8.16%

3-Year Return

300246.SZ
53.49%
SSE Composite Index
12.73%

5-Year Return

300246.SZ
30.24%
SSE Composite Index
5.21%

Compare To: 300246.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300246.SZ

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    1.73B

  • Enterprise Value

    1.82B

  • Trailing P/E

    20.08

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.50

  • Price/Book (mrq)

    1.19

  • Enterprise Value/Revenue

    1.44

  • Enterprise Value/EBITDA

    17.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.00%

  • Return on Assets (ttm)

    1.64%

  • Return on Equity (ttm)

    5.46%

  • Revenue (ttm)

    1.27B

  • Net Income Avi to Common (ttm)

    76.07M

  • Diluted EPS (ttm)

    0.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    490.99M

  • Total Debt/Equity (mrq)

    38.66%

  • Levered Free Cash Flow (ttm)

    -437.27M

Research Analysis: 300246.SZ

Analyst Price Targets

 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: 300246.SZ

People Also Watch